v3.25.2
Consolidated Statements of Stockholders' Deficit - USD ($)
Preferred Stock [Member]
Series A Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Series A Preferred Stock [Member]
Total
Balance at Dec. 31, 2022 $ 150 $ 2,611 $ 42,642,514 $ (51,412,128)   $ (8,766,853)
Balance, shares at Dec. 31, 2022 149,892 4,360        
Common Stock issued for acquisition of Cyren Assets $ 165 1,999,835   2,000,000
Common Stock issued for acquisition of Cyren Assets, shares   165,290        
Common stock issued for conversion of debt $ 12,857 344,735   357,592
Common stock issued for conversion of debt, shares   21,428        
Common Stock issued for adjustment to investors in private placement $ 45,619 (45,619)  
Common Stock issued for adjustment to investors in private placement, shares   77,010        
Warrant issued in conjunction with debts ⁽ⁱ⁾ 1,682,499   1,682,499
Stock-based compensation $ 312 974,290   974,602
Stock-based compensation, shares   4,786        
Net loss (4,244,708)   (4,244,708)
Balance at Dec. 31, 2023 $ 150 $ 61,564 47,598,254 (55,656,836)   (7,996,868)
Balance, shares at Dec. 31, 2023 149,892 272,874        
Common stock issued for conversion of debt $ 477 70,046   70,523
Common stock issued for conversion of debt, shares   477,349     400,000  
Stock-based compensation $ 31 924,863   924,894
Net loss       (6,087,182)   (6,087,182)
Common stock issued for conversion of preferred stock( (1) $ 400 (399)  
Common stock issued for conversion of preferred stock, shares   400,000        
Balance at Dec. 31, 2024 $ 149 $ 62,472 $ 48,592,764 $ (61,744,018)   $ (13,088,633)
Balance, shares at Dec. 31, 2024 149,492 1,150,223